SCHEMBL23930916

SCHEMBL23930916

CC(C)(C)OC(=O)N1CCC(n2ncc3c(Cl)c(C(=O)O)ccc32)CC1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 5/20 0.59
▸ GPR119 Q8TDV5 4/20 0.52
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ USP2 O75604 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ CYP3A4 P08684 2/20 0.47
▸ PIK3CA P42336 2/20 0.45
▸ MTOR P42345 2/20 0.45
▸ PIK3CG P48736 2/20 0.45
▸ ATR Q13535 2/20 0.45
▸ AURKB Q96GD4 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ CYP2C9 P11712 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31467845 0.81 NR3C1 (0.56) NR3C1GPR119MEN1KMT2AUSP2
SCHEMBL15325963 0.80 GPR119 (0.55) NR3C1GPR119KMT2ACYP3A4PIK3CA
SCHEMBL3956002 0.80 GPR119 (0.55) NR3C1GPR119MEN1KMT2AUSP2
SCHEMBL30588176 0.78 GPR119 (0.53) NR3C1GPR119CYP3A4PIK3CAMTOR
SCHEMBL26113241 0.78 GPR119 (0.53) NR3C1GPR119CYP3A4PIK3CAMTOR
SCHEMBL26135227 0.78 KMT2A (0.53) NR3C1GPR119MEN1KMT2AUSP2
SCHEMBL31467864 0.78 GPR119 (0.52) NR3C1GPR119CYP3A4PIK3CAMTOR
SCHEMBL31320725 0.78 GPR119 (0.52) NR3C1GPR119CYP3A4PIK3CAMTOR
SCHEMBL514912 0.78 GPR119 (0.52) NR3C1GPR119CYP3A4PIK3CAMTOR
SCHEMBL3614409 0.78 KMT2A (0.40) NR3C1MEN1KMT2AUSP2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021215545-A1 ANTICANCER COMBINATION THERAPY WITH N-(1-ACRYLOYL-AZETIDIN-3-YL)-2-((1H-INDAZOL-3-YL)AMINO)METHYL)-1H-IMIDAZOLE-5-CARBOXAMIDE INHIBITOR OF KRAS-G12C TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-10-28 — — WO disclosed
Send feedback